UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta-analysis

Heart (British Cardiac Society), 2012-08, Vol.98 (15), p.1127-1135

2012

Link zum Volltext

Verfügbarkeit prüfen

Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e004272

2022

Link zum Volltext

Verfügbarkeit prüfen

Child's buccal cell mitochondrial DNA content modifies the association between heart rate variability and recent air pollution exposure at school

Environment international, 2019-02, Vol.123, p.39-49

2019

Link zum Volltext

Verfügbarkeit prüfen

Minimizing operator exposure: field data analysis of three closed transfer systems for pesticide mixing and loading

Journal für Verbraucherschutz und Lebensmittelsicherheit, 2024, Vol.19 (2), p.143-153

2024

Link zum Volltext

Verfügbarkeit prüfen

How does under-reporting of negative and inconclusive results affect the false-positive rate in meta-analysis? A simulation study

BMJ open, 2014-08, Vol.4 (8), p.e004831-e004831

Kicinski, Michal

2014

Link zum Volltext

Verfügbarkeit prüfen

Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews

Statistics in medicine, 2015-09, Vol.34 (20), p.2781-2793

2015

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

The lancet oncology, 2021-05, Vol.22 (5), p.643-654

2021

Link zum Volltext

Verfügbarkeit prüfen

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Journal of clinical oncology, 2020-11, Vol.38 (33), p.3925-3936

2020

Link zum Volltext

Verfügbarkeit prüfen

Retinal microvascular responses to short-term changes in particulate air pollution in healthy adults

Environmental health perspectives, 2013-09, Vol.121 (9), p.1011-1016

2013

Link zum Volltext

Verfügbarkeit prüfen

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

JAMA oncology, 2020-04, Vol.6 (4), p.519

2020

Link zum Volltext

Verfügbarkeit prüfen

Estimation of Distant Metastasis–free Survival in Trials of Adjuvant Therapy for Melanoma

The New England journal of medicine, 2019-04, Vol.380 (14), p.1374-1377

2019

Link zum Volltext

Verfügbarkeit prüfen

Lower placental telomere length may be attributed to maternal residential traffic exposure; a twin study

Environment international, 2015-06, Vol.79, p.1-7

2015

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

The lancet oncology, 2021-05, Vol.22 (5), p.655-664

2021

Link zum Volltext

Verfügbarkeit prüfen

Neurobehavioral performance in adolescents is inversely associated with traffic exposure

Environment international, 2015-02, Vol.75, p.136-143

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

European journal of cancer (1990), 2019-07, Vol.116, p.148-157

2019

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of IKZF1plus in B‐cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial

Pediatric blood & cancer, 2023-06, Vol.70 (6), p.e30313-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of IKZF1 plus in B-cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial

Pediatric blood & cancer, 2023-06, Vol.70 (6), p.e30313

2023

Link zum Volltext

Verfügbarkeit prüfen

Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma

European journal of cancer (1990), 2021-11, Vol.158, p.156-168

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum levels of club cell secretory protein (Clara) and short- and long-term exposure to particulate air pollution in adolescents

Environment international, 2014-07, Vol.68, p.66-70

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta-analysis

Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054

Child's buccal cell mitochondrial DNA content modifies the association between heart rate variability and recent air pollution exposure at school

Minimizing operator exposure: field data analysis of three closed transfer systems for pesticide mixing and loading

Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype

Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: New recurrence-free survival results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial at three-year median follow-up

How does under-reporting of negative and inconclusive results affect the false-positive rate in meta-analysis? A simulation study

Prognostic and predictive value of an immune-related adverse event among stage III melanoma patients included in the EORTC 1325/KEYNOTE-054 pembrolizumab versus placebo trial

Long-term neurotoxicity among childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC Children Leukemia Group studies

Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

Retinal microvascular responses to short-term changes in particulate air pollution in healthy adults

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

Estimation of Distant Metastasis–free Survival in Trials of Adjuvant Therapy for Melanoma

Lower placental telomere length may be attributed to maternal residential traffic exposure; a twin study

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

Neurobehavioral performance in adolescents is inversely associated with traffic exposure

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

The prognostic value of IKZF1plus in B‐cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial

The prognostic value of IKZF1 plus in B-cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial

10-Day Decitabine Versus Intensive Chemotherapy Followed By Transplantation in Fit AML Patients Aged ≥60 Years: Health-Related Quality of Life Outcomes of the Randomized Phase III Trial AML21 of the EORTC Leukemia Group, Gimema, Celg, and Gmds-SG

Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma

Serum levels of club cell secretory protein (Clara) and short- and long-term exposure to particulate air pollution in adolescents

Aktive Filter

Suchergebnisse filtern